CMAP and Myosin-Loss Pathology in Patients With Critical Illness Myopathy

Dr. Gordon Smith talks with Drs. Shahar Shelly and Teerin Liewluck about the correlation between CMAP duration and myosin loss and their effect on mortality by comparing between patients with CIM with and without myosin loss.

Read the related article in Neurology. 

Disclosures can be found at Neurology.org.